CVRx, Inc. develops and manufactures medical devices. The Company specializes in technology for an implantable device for the treatment of hypertension and heart failure that triggers the body's master blood flow regulation system. CVRx serves customers worldwide.

Current Report (Form 8-K | Period ending 2024-11-04)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CVRx (CVRX US)

Current Report (Form 8-K | Period ending 2024-11-04)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-10-29)

Current Report (Form 8-K | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-08-27)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)